Sodium/Glucose Cotransporter (SGLT2) Inhibitors- Type 1 and Type 2 Diabetes Cohort Identification

Project Title Sodium/Glucose Cotransporter (SGLT2) Inhibitors- Type 1 and Type 2 Diabetes Cohort Identification
Date Posted
Monday, October 30, 2017
Project ID
soc_mpl1p_wp001
Status
Complete
Deliverables
Sentinel Modular Program Report: SGLT2 Inhibitors
Related Links
2017 ICPE Poster: Type 1 and Type 2 Diabetes Mellitus Identification Using ICD-9-CM Codes Within a Cohort of New Users of Drugs Labeled for Type 2 Diabetes Mellitus
Description

This report contains the estimated number of new users of Sodium/Glucose Cotransporter (SGLT-2) Inhibitors, Sulfonylureas, and Dipeptidyl peptidase-4 (DPP-4) Inhibitors among all users overall, users with Type I diabetes codes, and users with Type II diabetes codes.

Medical Product
dipeptidyl peptidase-4 (DPP-4) inhibitor
sodium-glucose cotransporter-2 (SGLT-2) inhibitor
sulfonylurea
Health Outcome
diabetes
type 1 diabetes mellitus
type 2 diabetes mellitus
Population / Cohort
All individuals
Time Period
April 1, 2013 - September 30, 2015
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Sentinel Distributed Database (SDD)
FDA Center
CDER
Scroll to Top